Cargando…
Travel Times to Facilities Offering Oral Medication Therapy for COVID-19
This quality improvement study evaluates access to oral COVID-19 therapeutics within communities in the 48 contiguous states and the District of Columbia.
Autores principales: | Kahn, Peter A., Ying, Xiaohan, Mathis, Walter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857170/ https://www.ncbi.nlm.nih.gov/pubmed/36595298 http://dx.doi.org/10.1001/jamanetworkopen.2022.49810 |
Ejemplares similares
-
Impact of a Medical Clinic Relocation on Travel Time: A Tale of 2
Modes of Transportation
por: Kahn, Peter A, et al.
Publicado: (2022) -
Availability and Accessibility of Live Nonreplicating Smallpox/Mpox Vaccine
por: Kahn, Peter A., et al.
Publicado: (2023) -
Air Travel in the Time of Covid-19 Pandemic: Precautions and Preventions
por: Brar, Rinnie, et al.
Publicado: (2022) -
Can Tofacitinib Offer Protection against COVID-19 Infection?
por: Goldberger, Tal, et al.
Publicado: (2021) -
Study of travellers’ preferences towards travel offer categories and incentives in the journey planning context
por: Malichová, Eva, et al.
Publicado: (2023)